Scientists have uncovered a surprising connection between sugar metabolism 🍬 and alcohol addiction 🍺, identifying a potential new therapeutic target for treating alcohol-associated liver disease (ALD) and alcohol use disorder (AUD).
Read Full Article
#SugarMetabolism #AlcoholAddiction #ALD #AUD #ResearchBreakthrough
Read Full Article
#SugarMetabolism #AlcoholAddiction #ALD #AUD #ResearchBreakthrough
CU Anschutz Medical Campus
One Enzyme Could be Behind Alcohol Addiction and Liver Disease
One Enzyme Could be Behind Alcohol Addiction and Liver Disease
Science News
A clinical trial has found that oral semaglutide reduces heavy drinking in adults with Alcohol Use Disorder (AUD). The study evaluated the oral formulation of semaglutide, which may be more acceptable for people with AUD than the injectable formulations previously…
✅ New Hope for Alcohol Use Disorder (AUD): A clinical trial led by CU Anschutz researchers found that oral semaglutide, a diabetes/weight loss drug, significantly reduced heavy drinking in adults with AUD.
✅ Key Trial Results: In an 8-week study of 50 adults, oral semaglutide led to fewer heavy drinking days, lower alcohol consumption per occasion, reduced cravings, and fewer alcohol-related problems.
✅ Broader Impact: The findings suggest oral semaglutide could be a new treatment option for AUD, especially for those not responding to current medications, potentially reducing alcohol-related harms for individuals and families.
#AUD #Semaglutide #MentalHealth
✅ Key Trial Results: In an 8-week study of 50 adults, oral semaglutide led to fewer heavy drinking days, lower alcohol consumption per occasion, reduced cravings, and fewer alcohol-related problems.
✅ Broader Impact: The findings suggest oral semaglutide could be a new treatment option for AUD, especially for those not responding to current medications, potentially reducing alcohol-related harms for individuals and families.
#AUD #Semaglutide #MentalHealth